Oak Grove Capital’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Oak Grove Capital's LLY Position: Q3 2026 in Review
Oak Grove Capital increased its Eli Lilly (LLY) stake by 61% in Q3 2026, buying an estimated $17.6M and bringing the position to 39,238 shares worth $45.4M. The position accounts for 2.05% of the portfolio, ranked #8.
Oak Grove Capital first reported a position in LLY in Q3 2022 and has held it in 17 quarters since. The position peaked at $78M in Q3 2024. 3,244 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Oak Grove Capital held 39,238 shares of Eli Lilly worth $45.4M as of Q3 2026.
- Oak Grove Capital bought 14,902 Eli Lilly shares in Q3 2026, an estimated $17.6M.
- Eli Lilly made up 2.05% of Oak Grove Capital's portfolio in Q3 2026, its #8 holding.
- Oak Grove Capital first reported a position in Eli Lilly in Q3 2022 and has held it in 17 quarters since.
- Oak Grove Capital's Eli Lilly position peaked at $78M in Q3 2024.
- 3,244 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Oak Grove Capital's 13F filing for Q3 2026, filed 9 Oct 2026.